Polynucleotides encoding anti-ganglioside antibodies
First Claim
Patent Images
1. An isolated polynucleotide comprising:
- a) the nucleotide sequence of SEQ ID NO;
1 or a nucleotide sequence encoding the amino acid sequence of SEQ ID NO;
2;
b) the nucleotide sequence of SEQ ID NO;
3 or a nucleotide sequence encoding the amino acid sequence of SEQ ID NO;
4;
c) the nucleotide sequence of SEQ ID NO;
19 or a nucleotide sequence encoding the amino acid sequence of SEQ ID NO;
20;
ord) the nucleotide sequence of SEQ ID NO;
21 or a nucleotide sequence encoding the amino acid sequence of SEQ ID NO;
22.
1 Assignment
0 Petitions
Accused Products
Abstract
IgM can be obtained in the form of a pentamer by placing the genes encoding the H, L, and J chains on the same vector to transform appropriate host cells. The gene encoding the J chain may be introduced by co-transfection. When no J chain is expressed, the IgM is produced as a hexamer. The transformants obtained according to the present invention achieve a high yield of IgM. The present invention also provides methods which enable separation and quantification of polymeric IgM.
-
Citations
25 Claims
-
1. An isolated polynucleotide comprising:
-
a) the nucleotide sequence of SEQ ID NO;
1 or a nucleotide sequence encoding the amino acid sequence of SEQ ID NO;
2;b) the nucleotide sequence of SEQ ID NO;
3 or a nucleotide sequence encoding the amino acid sequence of SEQ ID NO;
4;c) the nucleotide sequence of SEQ ID NO;
19 or a nucleotide sequence encoding the amino acid sequence of SEQ ID NO;
20;
ord) the nucleotide sequence of SEQ ID NO;
21 or a nucleotide sequence encoding the amino acid sequence of SEQ ID NO;
22. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)
-
Specification